Bhardwaj [38] attempted to distinguish between DCM patients who responded and those who did not respond to immunoadsorption at the proteomics level, and they found that the proteins S100-A8, perilipin-4, and kininogen-1 had the potential to help stratify patients with immunoadsorption therapy. Here, S100A8 is linked to familial dilated cardiomyopathy.